Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors – A phase I trial

Overview of attention for article published in Frontiers in immunology, October 2022

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 2,813 followers.

💉 Vaccinating against suppressive immune modulators to target their producers in the TME => https://t.co/jfxHpm5Fqv https://t.co/3lkXqlPso9

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.